|
|
| | Eleclazine Basic information |
| Product Name: | Eleclazine | | Synonyms: | Eleclazine;GS6615;GS 6615;Eleclazine(GS-6615);GS6615;GS 6615;1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-;4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one;Eleclazine free base | | CAS: | 1443211-72-0 | | MF: | C21H16F3N3O3 | | MW: | 415.37 | | EINECS: | | | Product Categories: | | | Mol File: | 1443211-72-0.mol |  |
| | Eleclazine Chemical Properties |
| Melting point | 72 - 74°C | | Boiling point | 544.8±50.0 °C(Predicted) | | density | 1.370±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 0.37±0.13(Predicted) | | form | Solid | | color | Pale Beige to Beige |
| | Eleclazine Usage And Synthesis |
| Uses | ELECLAZINE (cas# 1443211-72-0) is a late sodium current inhibitor and a phase II agent with demonstrated pre-clinical anti-ischemic and antiarrhythmic properties. |
| | Eleclazine Preparation Products And Raw materials |
|